Auna SA (AUNA) vs Bio-Rad Laboratories, Inc. (BIO)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| AUNA | BIO | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Devices |
| Size band | SMALL | MID |
| Listing | NYSE | NYSE |
| Country | Luxembourg | United States |
| Theme | hospitals-and-providers | life-science-tools |
| Price and returns | ||
| Last close | $4.99 | $372.43 |
| Return · 1 week | −7.25% | +5.56% |
| Return · 1 month | −0.60% | −1.39% |
| Return · 3 months | −4.04% | +12.52% |
| Return · year to date | +4.83% | +22.00% |
| Return · 1 year | −17.25% | +10.80% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −25.58% | −6.01% |
| 52-week high | $6.71 | $396.23 |
| 52-week low | $4.09 | $236.73 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $369.54M | $9.97B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $593.56K | $93.82M |
| Employees | 14,796 | 7,450 |
| Valuation | ||
| Price to earnings · trailing | 86.00× | 46.41× |
| Price to earnings · forward | 4.76× | 36.92× |
| Price to sales | 0.08× | 3.78× |
| Price to book | 0.73× | 1.36× |
| Enterprise value to EBITDA | 4.90× | 21.75× |
| Enterprise value to revenue | 0.83× | 3.70× |
| PEG ratio | — | 4.01 |
| Earnings per share · trailing | 0.06 | 7.89 |
| Profitability | ||
| Gross margin | 36.89% | 51.90% |
| Operating margin | 13.09% | 11.18% |
| Profit margin | 0.35% | 8.59% |
| Return on equity | 1.62% | 3.11% |
| Return on assets | 5.22% | 1.66% |
| Growth | ||
| Revenue growth | +13.20% | −0.10% |
| Earnings growth | −64.00% | +18.70% |
| Balance sheet and payout | ||
| Debt / equity (%) | 184.96 | 19.10 |
| Current ratio | 1.08 | 3.14 |
| Dividend yield | 0.00% | 0.00% |
| Payout ratio | 0.00% | 0.00% |
| Trend and volatility | ||
| RSI · 14 | 41.57 | 54.82 |
| ADX · 14 | 24.80 | 17.76 |
| 50-day average | $5.19 | $373.32 |
| 200-day average | $5.12 | $312.23 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.55% | 3.00% |
The full AUNA analysis
Everything this table leaves out for Auna SA: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the AUNA argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full AUNA analysisThe full BIO analysis
Everything this table leaves out for Bio-Rad Laboratories, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BIO argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BIO analysis